| . | Antibiotic intervention (n = 45) . | Control (n = 41) . |
|---|---|---|
| Total J01/1000 registered patients/year | 280 (146–560) | 286 (144–733) |
| J01A + J01CA + J01CE/1000 registered patients/year | 111 (46–240) | 117 (48–244) |
| J01CR + J01FA/1000 registered patients/year | 66 (27–169) | 66 (27–217) |
| Overprescribing for RTIs | 44% (0%–89%) | ND |
| Overprescribing for AOM | 2.4% (0%–50%) | ND |
| Overprescribing for sore throat | 54% (0%–100%) | ND |
| Overprescribing for rhinosinusitis | 52% (0%–100%) | ND |
| Overprescribing for lower RTIs | 48% (0%–100%) | ND |
| Non-first-choice prescribing for RTIs | 22% (0%–72%) | ND |
| Underprescribing for RTIs | 2.9% (0%–17%) | ND |
| . | Antibiotic intervention (n = 45) . | Control (n = 41) . |
|---|---|---|
| Total J01/1000 registered patients/year | 280 (146–560) | 286 (144–733) |
| J01A + J01CA + J01CE/1000 registered patients/year | 111 (46–240) | 117 (48–244) |
| J01CR + J01FA/1000 registered patients/year | 66 (27–169) | 66 (27–217) |
| Overprescribing for RTIs | 44% (0%–89%) | ND |
| Overprescribing for AOM | 2.4% (0%–50%) | ND |
| Overprescribing for sore throat | 54% (0%–100%) | ND |
| Overprescribing for rhinosinusitis | 52% (0%–100%) | ND |
| Overprescribing for lower RTIs | 48% (0%–100%) | ND |
| Non-first-choice prescribing for RTIs | 22% (0%–72%) | ND |
| Underprescribing for RTIs | 2.9% (0%–17%) | ND |
ND, not determined.
Dispensed antibiotics in the exact year preceding the intervention are presented as practice-based mean values with ranges. Overprescribing, underprescribing and non-first-choice prescribing were derived from a 4 week registration of RTIs and are presented as practice-based mean values with ranges.
| . | Antibiotic intervention (n = 45) . | Control (n = 41) . |
|---|---|---|
| Total J01/1000 registered patients/year | 280 (146–560) | 286 (144–733) |
| J01A + J01CA + J01CE/1000 registered patients/year | 111 (46–240) | 117 (48–244) |
| J01CR + J01FA/1000 registered patients/year | 66 (27–169) | 66 (27–217) |
| Overprescribing for RTIs | 44% (0%–89%) | ND |
| Overprescribing for AOM | 2.4% (0%–50%) | ND |
| Overprescribing for sore throat | 54% (0%–100%) | ND |
| Overprescribing for rhinosinusitis | 52% (0%–100%) | ND |
| Overprescribing for lower RTIs | 48% (0%–100%) | ND |
| Non-first-choice prescribing for RTIs | 22% (0%–72%) | ND |
| Underprescribing for RTIs | 2.9% (0%–17%) | ND |
| . | Antibiotic intervention (n = 45) . | Control (n = 41) . |
|---|---|---|
| Total J01/1000 registered patients/year | 280 (146–560) | 286 (144–733) |
| J01A + J01CA + J01CE/1000 registered patients/year | 111 (46–240) | 117 (48–244) |
| J01CR + J01FA/1000 registered patients/year | 66 (27–169) | 66 (27–217) |
| Overprescribing for RTIs | 44% (0%–89%) | ND |
| Overprescribing for AOM | 2.4% (0%–50%) | ND |
| Overprescribing for sore throat | 54% (0%–100%) | ND |
| Overprescribing for rhinosinusitis | 52% (0%–100%) | ND |
| Overprescribing for lower RTIs | 48% (0%–100%) | ND |
| Non-first-choice prescribing for RTIs | 22% (0%–72%) | ND |
| Underprescribing for RTIs | 2.9% (0%–17%) | ND |
ND, not determined.
Dispensed antibiotics in the exact year preceding the intervention are presented as practice-based mean values with ranges. Overprescribing, underprescribing and non-first-choice prescribing were derived from a 4 week registration of RTIs and are presented as practice-based mean values with ranges.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
